Edition:
United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

2.48USD
24 Mar 2017
Change (% chg)

$0.06 (+2.48%)
Prev Close
$2.42
Open
$2.41
Day's High
$2.50
Day's Low
$2.41
Volume
571,555
Avg. Vol
205,153
52-wk High
$3.31
52-wk Low
$1.20

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

James Geraghty

61 2013 Independent Chairman of the Board

Vincent Milano

52 2014 President, Chief Executive Officer, Director

Youssef El Zein

66 1997 Independent Vice Chairman of the Board

Louis Arcudi

54 2011 Chief Financial Officer, Senior Vice President - Operations, Treasurer, Secretary

Robert Fletcher

52 2015 Senior Vice President - Business Development and Strategic Planning